PMC:7787218 / 9654-10208 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"149","span":{"begin":80,"end":90},"obj":"Species"},{"id":"150","span":{"begin":108,"end":118},"obj":"Species"},{"id":"151","span":{"begin":355,"end":362},"obj":"Species"},{"id":"152","span":{"begin":435,"end":445},"obj":"Species"},{"id":"153","span":{"begin":532,"end":540},"obj":"Species"},{"id":"168","span":{"begin":2,"end":7},"obj":"Chemical"},{"id":"169","span":{"begin":183,"end":197},"obj":"Chemical"},{"id":"170","span":{"begin":268,"end":271},"obj":"Chemical"}],"attributes":[{"id":"A149","pred":"tao:has_database_id","subj":"149","obj":"Tax:2697049"},{"id":"A150","pred":"tao:has_database_id","subj":"150","obj":"Tax:10508"},{"id":"A151","pred":"tao:has_database_id","subj":"151","obj":"Tax:9606"},{"id":"A152","pred":"tao:has_database_id","subj":"152","obj":"Tax:2697049"},{"id":"A153","pred":"tao:has_database_id","subj":"153","obj":"Tax:9606"},{"id":"A168","pred":"tao:has_database_id","subj":"168","obj":"MESH:D008055"},{"id":"A169","pred":"tao:has_database_id","subj":"169","obj":"MESH:D011136"},{"id":"A170","pred":"tao:has_database_id","subj":"170","obj":"MESH:D011092"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"e lipid mixtures (see Table 1) — is unknown. The implications for future use of SARS-CoV-2 vaccines with an adenovirus carrier and protein subunit, which are commonly formulated with polysorbate 80, a nonionic surfactant and emulsifier that has a structure similar to PEG, are also currently unknown.6,13 According to the current CDC recommendations, all persons with a history of an anaphylactic reaction to any component of the mRNA SARS-Cov-2 vaccines should avoid these vaccines, and this recommendation would currently exclude patients with a histor"}